Phosphodiesterase Type 4 Inhibition in CNS Diseases
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 40, Issue 12, Pages 971-985Publisher
ELSEVIER SCIENCE LONDON
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Clinical Implication of Phosphodiesterase-4-Inhibition
Martin Alexander Schick, Nicolas Schlegel
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases
Andrea Picchianti-Diamanti, Francesca Romana Spinelli, Maria Manuela Rosado, Fabrizio Conti, Bruno Lagana
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway
Cheng Ju, Fangyu Yuan, Lu Wang, Caixia Zang, Jingwen Ning, Meiyu Shang, Jingwei Ma, Gen Li, Yang Yang, Qiuzhu Chen, Yueqi Jiang, Fangfang Li, Xiuqi Bao, Dan Zhang
NEUROBIOLOGY OF DISEASE (2023)
In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters
Vitor S. Fernandes, Maria Elvira Lopez-Oliva, Maria Pilar Martinez, Angel Agis-Torres, Paz Recio, Jorge Navarro-Dorado, Maria Victoria Barahona, Sara Benedito, Dolores Prieto, Belen Climent, Medardo Hernandez
LIFE SCIENCES (2022)
Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice
Fang-fang Zhang, Hao Wang, Yan-meng Zhou, Hai-yang Yu, Melanie Zhang, Xian Du, Dong Wang, Feng Zhang, Ying Xu, Ji-guo Zhang, Han-Ting Zhang
CNS NEUROSCIENCE & THERAPEUTICS (2022)
Stress resilience-enhancing drugs preserve tissue structure and function in degenerating retina via phosphodiesterase inhibition
Jennings C. Luu, Aicha Saadane, Henri Leinonen, Elliot H. Choi, Fangyuan Gao, Dominik Lewandowski, Maximilian Halabi, Christopher L. Sander, Arum Wu, Jacob M. Wang, Rupesh Singh, Songqi Gao, Emma M. Lessieur, Zhiqian Dong, Grazyna Palczewska, Robert F. Mullins, Neal S. Peachey, Philip D. Kiser, Marcin Tabaka, Timothy S. Kern, Krzysztof Palczewski
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Phosphodiesterases type 2, 3 and 4 promote vascular tone in mesenteric arteries from rats with heart failure
Liting Wang, Fabien Hubert, Sarah Idres, Milia Belacel-Ouari, Valerie Domergue, Severine Domenichini, Florence Lefebvre, Delphine Mika, Rodolphe Fischmeister, Veronique Leblais, Boris Manoury
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease
Mirco Govoni, Michele Bassi, Debora Santoro, Sinead Donegan, Dave Singh
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)
Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis
Jose Luis Morgado-Pascual, Beatriz Suarez-Alvarez, Vanessa Marchant, Pamela Basantes, Pierre-Louis Tharaux, Alberto Ortiz, Carlos Lopez-Larrea, Marta Ruiz-Ortega, Sandra Rayego-Mateos
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Oxygen-Promoted 6-endo-trig Cyclization of & beta;,& gamma;-Unsaturated Hydrazones/Ketoximes with Diazonium Tetrafluoroborates for Pyridazin-4(1H)-ones/Oxazin-4(1H)-ones
Zhenjie Qi, Simiaomiao Wen, Zhao Liu, Dongfang Jiang
ORGANIC LETTERS (2023)
PDE inhibition in distinct cell types to reclaim the balance of synaptic plasticity
Ben Rombaut, Sofie Kessels, Melissa Schepers, Assia Tiane, Dean Paes, Yevgeniya Solomina, Elisabeth Piccart, Daniel van den Hove, Bert Brone, Jos Prickaerts, Tim Vanmierlo
THERANOSTICS (2021)
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
Theerasuk Kawamatawong
FRONTIERS IN PHARMACOLOGY (2021)
Locus for severity implicates CNS resilience in progression of multiple sclerosis
Adil Harroud, Pernilla J. Stridh, Jacob H. McCauley, Janna Saarela, Aletta M. R. van den Bosch, Hendrik Engelenburg, Ashley Beecham, Lars Alfredsson, Katayoun Alikhani, Lilyana Amezcua, Till F. M. Andlauer, Maria Ban, Lisa Barcellos, Nadia Barizzone, Tone Berge, Achim Berthele, Stefan Bittner, Steffan Bos, Farren B. S. Briggs, Stacy Caillier, Peter Calabresi, Domenico Caputo, David Carmona-Burgos, Paola Cavalla, Elisabeth Celius, Gabriel Cerono, Angel Chinea, Tanuja Chitnis, Ferdinando Clarelli, Manuel Comabella, Giancarlo Comi, Chris Cotsapas, Bruce C. A. Cree, Sandra D'Alfonso, Efthimios Dardiotis, Philip De Jager, Silvia Delgado, Benedicte Dubois, Sinah Engel, Federica Esposito, Marzena Fabis-Pedrini, Massimo Filippi, Kathryn Fitzgerald, Christiane Gasperi, Lissette Gomez, Refujia Gomez, Georgios Hadjigeorgiou, Joerg Hamann, Friederike Held, Roland Henry, Jan Hillert, Jesse Huang, Inge Huitinga, Talat Islam, Noriko Isobe, Maja Jagodic, Allan L. Kermode, Michael Khalil, Trevor Kilpatrick, Ioanna Konidari, Karim Kreft, Jeannette Lechner-Scott, Maurizio Leone, Felix Luessi, Sunny Malhotra, Ali Manouchehrinia, Clara Manrique, Filippo Martinelli-Boneschi, Andrea Martinez, Viviana Martinez-Maldonado, Elisabetta Mascia, Luanne Metz, Luciana Midaglia, Xavier Montalban, Jorge Oksenberg, Tomas Olsson, Annette Oturai, Kimmo Paakkonen, Grant P. Parnell, Nikolaos Patsopoulos, Margaret Pericak-Vance, Fredrik Piehl, Justin Rubio, Adam Santaniello, Silvia Santoro, Catherine Schaefer, Finn Sellebjerg, Hengameh Shams, Klementy Shchetynsky, Claudia Silva, Vasileios Siokas, Helle Sondergaard, Melissa Sorosina, Bruce Taylor, Marijne Vandebergh, Elena Vasileiou, Domizia Vecchio, Margarete Voortman, Howard Weiner, Dennis Wever, V. Wee Yong, David Hafler, Graeme Stewart, Alastair Compston, Frauke Zipp, Hanne Harbo, Bernhard Hemmer, An Goris, Joost Smolders, Stephen Hauser, Ingrid Kockum, Stephen Sawcer, Sergio Baranzini, Ingileif Jonsdottir, Yolanda Blanco, Sara Llufriu, Lohith Madireddy, Albert Saiz, Pablo Villoslada, Kari Stefansson, Hanne F. Harbo, Bernhard Hemmer, An Goris, Ingrid Kockum, Stephen J. Sawcer, Sergio E. Baranzini
NATURE (2023)
Autoimmune polyglandular syndrome type 4: experience from a single reference center
Elisa Gatta, Valentina Anelli, Elena Cimino, Elena Di Lodovico, Elda Piovani, Irene Zammarchi, Giorgia Gozzoli, Virginia Maltese, Maria Cavadini, Barbara Agosti, Andrea Delbarba, Ilenia Pirola, Angela Girelli, Caterina Buoso, Francesca Bambini, Daniele Alfieri, Walter Bremi, Paolo Facondo, Roberto Lupo, Francesco Bezzi, Micaela Fredi, Anna Maria Mazzola, Elena Gandossi, Maura Saullo, Fiorella Marini, Massimo Licini, Letizia Chiara Pezzaioli, Laura Pini, Franco Franceschini, Chiara Ricci, Carlo Cappelli
FRONTIERS IN ENDOCRINOLOGY (2023)
Nanoparticles: A Hope for the Treatment of Inflammation in CNS
Feng-Dan Zhu, Yu-Jiao Hu, Lu Yu, Xiao-Gang Zhou, Jian-Ming Wu, Yong Tang, Da-Lian Qin, Qing-Ze Fan, An-Guo Wu
FRONTIERS IN PHARMACOLOGY (2021)
The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms
Ellis Nelissen, Nina Possemis, Nick P. Van Goethem, Melissa Schepers, Danielle A. J. Mulder-Jongen, Lisa Dietz, Wiebke Janssen, Michael Gerisch, Jorg Huser, Peter Sandner, Tim Vanmierlo, Jos Prickaerts
SCIENTIFIC REPORTS (2022)
Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases
Na Zhan, Boyang Wang, Nikita Martens, Yankai Liu, Shangge Zhao, Gardi Voortman, Jeroen Van Rooij, Frank Leijten, Tim Vanmierlo, Folkert Kuipers, Johan W. Jonker, Vincent W. Bloks, Dieter Luetjohann, Marcella Palumbo, Francesca Zimetti, Maria Pia Adorni, Hongbing Liu, Monique T. Mulder
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
A perspective on causality assessment in epigenetic research on neurodegenerative disorders
Philippos Koulousakis, Assia Tiane, Niels Hellings, Jos Prickaerts, Daniel van den Hove, Tim Vanmierlo
NEURAL REGENERATION RESEARCH (2023)
Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis
Melissa Schepers, Dean Paes, Assia Tiane, Ben Rombaut, Elisabeth Piccart, Lieve van Veggel, Pascal Gervois, Esther Wolfs, Ivo Lambrichts, Chiara Brullo, Olga Bruno, Ernesto Fedele, Roberta Ricciarelli, Charles Ffrench-Constant, Marie E. Bechler, Pauline van Schaik, Wia Baron, Evy Lefevere, Kobi Wasner, Anne Grunewald, Catherine Verfaillie, Paulien Baeten, Bieke Broux, Paul Wieringa, Niels Hellings, Jos Prickaerts, Tim Vanmierlo
BRAIN BEHAVIOR AND IMMUNITY (2023)
Phosphodiesterase (PDE) 4 inhibition boosts Schwann cell myelination in a 3D regeneration model
Melissa Schepers, Afonso Malheiro, Adrian Seijas Gamardo, Niels Hellings, Jos Prickaerts, Lorenzo Moroni, Tim Vanmierlo, Paul Wieringa
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)
Therapeutic administration of mouse mast cell protease 6 improves functional recovery after traumatic spinal cord injury in mice by promoting remyelination and reducing glial scar formation
Tim Vangansewinkel, Stefanie Lemmens, Assia Tiane, Nathalie Geurts, Dearbhaile Dooley, Tim Vanmierlo, Gunnar Pejler, Sven Hendrix
FASEB JOURNAL (2023)
Unleashing Spinal Cord Repair: The Role of cAMP-Specific PDE Inhibition in Attenuating Neuroinflammation and Boosting Regeneration after Traumatic Spinal Cord Injury
Femke Mussen, Jana Van Broeckhoven, Niels Hellings, Melissa Schepers, Tim Vanmierlo
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Generation of a ST3GAL3 null mutant induced pluripotent stem cell (iPSC) line (UKWMPi002-A-3) by CRISPR/Cas9 genome editing
David Diouf, Maria Rosaria Vitale, Johanna Eva Maria Zoeller, Ana -Magdalena Pineau, Eva Klopocki, Catharina Hamann, Georg Christoph Ziegler, Tim Vanmierlo, Daniel Van den Hove, Klaus-Peter Lesch
STEM CELL RESEARCH (2023)
Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?
Ellis Nelissen, Melissa Schepers, Laura Ponsaerts, Sebastien Foulquier, Annelies Bronckaers, Tim Vanmierlo, Peter Sandner, Jos Prickaerts
PHARMACOLOGICAL RESEARCH (2023)
Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?
Nikita Martens, Na Zhan, Gardi Voortman, Frank P. J. Leijten, Connor van Rheenen, Suzanne van Leerdam, Xicheng Geng, Michiel Huybrechts, Hongbing Liu, Johan W. W. Jonker, Folkert Kuipers, Dieter Lutjohann, Tim Vanmierlo, Monique T. T. Mulder
NUTRIENTS (2023)
Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720
Alessandra Roggeri, Guendalina Olivero, Cesare Usai, Tim Vanmierlo, Anna Pittaluga
CELLS (2023)
Brain-penetrant sGC stimulator BAY-747 and activator runcaciguat act as cognitive enhancers via differential neuroplastic mechanisms
Ellis Nelissen, Tim Vanmierlo, Peter Sandner, Jos Prickaerts
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
sGC modulators as cognitive enhancers: neuronal and/ or vascular?
Jos Prickaerts, Ellis Nelissen, Tim Vanmierlo, Peter Sandner
JOURNAL OF TRANSLATIONAL MEDICINE (2023)
INCREASING CAMP LEVELS BY INHIBITING PHOSPHODIESTERASE 4D IMPROVES NERVE CONDUCTION AND FUNCTIONAL RECOVERY IN A MOUSE MODEL FOR CHARCOT MARIE TOOT 1A
Tim Vangansewinkel, Melissa Schepers, Karen Libberecht, Darren Jacobs, Elisabeth Piccart, Hanne Jeurissen, Robert Prior, Roberta Ricciarelli, Olga Bruno, Ernesto Fedele, Chiara Brullo, Jos Prickaerts, Ludo Van Den Bosch, Tim Vanmierlo, Ivo Lambrichts, Esther Wolfs
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2022)
The Selective Sphingosine-1-Phosphate Receptor 1 (S1P1) Modulator Ponesimod Enhances Murine Oligodendrocyte Precursor Cell (OPC) Differentiation and Retains OPC Migration
M. Ait-Tihyaty, E. Piccart, M. Schepers, E. Willems, A. DiBernardo, T. Vanmierlo
MULTIPLE SCLEROSIS JOURNAL (2022)